
JPMorgan Q2 profit landed at $21.2 billion, or $7.70 per share, the largest quarterly result ever booked in US banking. The tape was carried by a $4.6 billion mark-to-market gain on the Visa Inc stake plus another $1 billion of equity investment gains, but even stripped of those items the bank still cleared $16.9 billion of net income and $6.14 in EPS, with a return on tangible common equity at 23%. Managed revenue rose 27% year over year to $58 billion, and every single line of business posted record revenue for the quarter. Equity Markets revenue jumped 86% year over year to $6 billion, Fixed Income gained 6%, and Investment banking fees rose 30% to $3.3 billion. Beneath those numbers sits one catalyst nobody at JPMorgan planned for eighteen months ago: the June 12 SpaceX IPO, the largest listing in history at a $1.77 trillion valuation and roughly $85.7 billion raised. This piece walks through the headline print, unpacks how the Visa mark and the SpaceX deal fees stacked into the beat, then lays out the bull case for a full-year 2026 upgrade and the bear case if trading normalizes into the back half.
The Read
- Q2 net income $21.2B is the highest quarterly profit in U.S. banking history, EPS $7.70.
- Excluding the $4.6B Visa mark and $1B equity gains, core net income was $16.9B with EPS $6.14 and 23% ROTCE.
- Every line of business set a record, with Equity Markets +86% YoY at $6B and IB fees +30% at $3.3B.
JPMorgan Books $21.2B Net Income With Every Line of Business at a Record
The $21.2 billion JPMorgan Q2 profit print sits above any quarter JPMorgan has ever booked, and above any quarter any U.S. bank has ever booked. The bank framed the number as “record revenue across every business”, which is unusual language and hard to falsify given the segment split. Equity Markets revenue at $6 billion is up 86% year over year, Fixed Income rose 6% to bring total Markets to $12.1 billion, and Investment banking fees at $3.3 billion are the highest since 2021.
The headline EPS at $7.70 needs the two known one-timers stripped out to read cleanly. Adjusted for the $4.6 billion Visa mark-to-market and the $1 billion of equity investment gains, core net income lands at $16.9 billion and EPS at $6.14. A 23% return on tangible common equity on that adjusted base is the number sell-side analysts will lead their models with going forward, not the reported $7.70.
Managed revenue growth of 27% year over year to $58 billion is the most structurally interesting line. That growth rate is running well above the U.S. GDP growth pace and above what analysts had modeled for the biggest U.S. bank in a mid-cycle environment. Bulls will read that as operating leverage kicking in, especially given the boost from the SpaceX IPO priced at a $1.77 trillion valuation on June 12. Bears will read it as a cyclical peak unlikely to be repeated in H2.

Visa Mark and SpaceX Deal Fees Drove the Bulk of the Q2 Beat
The $4.6 billion Visa gain is a straightforward mark-to-market on shares JPMorgan holds. It boosts reported profit but does not signal recurring franchise strength. Take it out and JPMorgan still had a great quarter, but not a historic one. The recurring part of the JPMorgan Q2 profit beat sits inside Investment banking fees at $3.3 billion, the highest print since 2021, and Equity Markets revenue at $6 billion.
The single most consequential catalyst behind those franchise numbers is the June 12 SpaceX IPO. The SpaceX listing raised roughly $85.7 billion at a $1.77 trillion valuation, the largest IPO in history, and JPMorgan sat in the lead underwriter syndicate on the deal. Even under-market underwriting spreads on a book that size compound into hundreds of millions of fee revenue. That single deal explains a large part of the 30% year-over-year jump in Investment banking fees.
Equity Markets at plus 86% year over year is also downstream of the SpaceX print, not just its aftermath. SpaceX’s inclusion in the Nasdaq-100 triggered roughly $4.3 billion of forced index buying, and desks that could warehouse the flow captured spread that shows up in the Equity Markets line. JPMorgan sits at the very top of the pecking order for that kind of volume, and its share of the reprice trade was almost mechanically outsized.
One thing to notice is how much of the beat is genuinely repeatable. Investment banking fees at 2021 levels reflect a real reopening of the IPO calendar, not just SpaceX being an outlier. If OpenAI, Databricks and a handful of other pre-IPO names actually list in H1 2027, JPMorgan is positioned to be lead on multiple of them.
Also on CFinance:
- IBM Q2 Warning Sends Stock Down 25% on AI Capex Shift
- Payout Ratio Reveals What Dividend Yield Hides
- Coinbase Stock at $158, 64% Below Its 52-Week High
Full-Year Beat Setup Holds If Q3 Trading Doesn’t Roll Over
The bull case for a full-year 2026 upgrade cycle rests on three legs. First, the Visa mark is nonrecurring but does not need to repeat for JPMorgan to beat consensus in Q3 and Q4, because the trading uplift alone is running above prior guidance. Second, the IPO pipeline into H2 2026 is real and Dimon has already flagged it publicly. Third, the rate curve keeps net interest income sticky enough to avoid the kind of NII air pocket regional banks are still fighting.
Add to that the broader Q2 backdrop. The S&P 500 just posted its best Q2 since 2020, with chip stocks and the AI trade doing most of the lifting. Bank stocks tend to derate late in that kind of rally, which is where JPMorgan has room to be a defensive Magnificent-7-adjacent name. On the ROTCE math, 23% adjusted is a book-multiple story, not an earnings-multiple story, and that historically compresses the valuation to book below the level where JPMorgan currently trades.
Here is why the setup is not fragile. Even a Q3 print that misses the record JPMorgan Q2 profit by 15-20% would still leave the H2 run-rate above the consensus that street models were carrying entering earnings season. The bar for a bull thesis to hold has been mechanically lowered by the size of the Q2 beat.
Ex-Gains EPS at $6.14 Shows the Core Earnings Base Below the Headline
The bear case starts with the same $6.14 core EPS number. Once the Visa mark and equity gains are stripped, the “record” framing gets thinner. $16.9 billion of adjusted net income is a great quarter but not a paradigm shift, and Q3 will not have another $4.6 billion Visa windfall to lean on. If trading volumes revert to a more normal seasonal pattern in July and August, the H2 run-rate compresses toward the $14-15 billion range per quarter.
The IPO calendar is also uneven. SpaceX was a $1.77 trillion outlier, not a template. If Databricks or Stripe delay to 2027, Investment banking fees revert to the mid-teens billion annual pace instead of the 30% growth trajectory Q2 implied. Equity Markets at plus 86% year over year is also a hard comp for Q2 2027, when JPMorgan will be lapping this quarter rather than an easier prior-year base.
The other side of this is that consumer credit is quietly showing early signs of deterioration in the sell-side notes coming out of Card and Auto. If cumulative charge-offs pick up in H2, JPMorgan will reserve into it, and reserves are the fastest way to compress reported EPS regardless of how good trading revenue prints. That is the scenario where the stock takes back its Q2 gain even if the operating franchise is clearly the strongest in U.S. banking.
More to come.




